ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0436

Family Planning in Rheumatology: A Single Center Quality Improvement Project

Sara Heard, Elena Cravens, Jeanne Gosselin and Juvena Hitt, University of Vermont Medical Center, Burlington, VT

Meeting: ACR Convergence 2024

Keywords: autoimmune diseases, pregnancy, Surveys, Women's health

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Reproductive Issues in Rheumatic Disorders Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Pregnancy in patients with rheumatologic disease can lead to serious maternal and fetal complications. Multinational surveys have shown that medical providers often fail to give adequate family planning information and support to patients of childbearing age with rheumatologic diseases. Several QI projects have implemented standardized pregnancy intention screening questions in rheumatology clinics demonstrating improved pregnancy counseling. We conducted a needs assessment in our institution with rheumatology and OBGYN providers. The aims of this project were to gauge patient satisfaction and provider comfort in family planning discussions and increase screening for family planning desires amongst patients of childbearing age.

Methods: Online REDCap surveys were launched for patients (N=246, 191 pre-intervention, 55 post-intervention), rheumatology providers (N=8), and OBGYN residents (N=8). Rheumatology and OBGYN providers were surveyed for comfort with family planning conversations with patients with autoimmune disease. Patients – women and transgender men (age 18-50) – were asked about pregnancy desires, comfort with rheumatologic medications and contraception method, and satisfaction with family planning conversations. Our primary intervention was implementation of the validated One Key Question during the clinic rooming process: “Do you want to become pregnant in the next 12 months?” Secondary interventions included a grand rounds presentation, smart phrases for providers, billing codes for general counseling on contraception, and laminated contraception handouts in clinic. Patient survey results were collected pre- and post-intervention and analyzed with Chi-square, Fisher’s exact, Mann-Whitney tests using Stata 18 software.

Results: Pre-intervention survey data showed 50% of rheumatology providers feel they inadequately address pregnancy planning with their patients, and 88% of OBGYN residents feel uncomfortable managing patients with autoimmune disease during pregnancy. Post-intervention data showed an increase in percentage of patients screened for pregnancy intention, from 18% to 84% (p=0.000). Patient satisfaction with family planning conversations pre- vs. post-intervention was unchanged (p=1.000), as was patient comfort with rheumatologic medications and contraception method (p=0.6737 and p=0.7454, respectively).

Conclusion: We instituted an effective QI intervention that significantly increased family planning screening in the rheumatology clinic. OBGYN and rheumatology provider survey results demonstrate a care gap necessitating future efforts to improve interdisciplinary management of patients with immune mediated inflammatory disease. We did not see a statistically significant change in patient satisfaction with family planning discussions or comfort with medications and contraception method. Next steps include collecting post-intervention provider survey data and administering patient surveys at 6-month intervals throughout the next year. We expect that screening with the One Key Question will continue to stimulate family planning conversations and improve provider and patient comfort and satisfaction.

Supporting image 1

Percentage of patients screened with the One Key Question (“Do you want to become pregnant in the next 12 months?”) increased from 18% to 84% after implementation of our primary intervention (p=0.000).

Supporting image 2

Pre-intervention provider survey results showed that 50% of rheumatology providers felt that they inadequately addressed pregnancy discussions with their patients.

Supporting image 3

Pre-intervention OBGYN survey results showed that 88% of OBGYN residents felt somewhat or very uncomfortable with management of their patients with rheumatic disease.


Disclosures: S. Heard: None; E. Cravens: None; J. Gosselin: None; J. Hitt: None.

To cite this abstract in AMA style:

Heard S, Cravens E, Gosselin J, Hitt J. Family Planning in Rheumatology: A Single Center Quality Improvement Project [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/family-planning-in-rheumatology-a-single-center-quality-improvement-project/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/family-planning-in-rheumatology-a-single-center-quality-improvement-project/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology